MARKET

DXCM

DXCM

DexCom
NASDAQ

Real-time Quotes | Nasdaq Last Sale

267.85
-10.15
-3.65%
Opening 12:55 03/31 EDT
OPEN
272.63
PREV CLOSE
278.00
HIGH
277.08
LOW
263.54
VOLUME
712.03K
TURNOVER
--
52 WEEK HIGH
306.71
52 WEEK LOW
107.44
MARKET CAP
24.53B
P/E (TTM)
247.30
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of DXCM and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 19 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average DXCM stock price target is 290.06 with a high estimate of 330.00 and a low estimate of 240.00.

EPS

DXCM News

More
  • Here's Why You Should Add DexCom (DXCM) to Your Portfolio Now
  • Zacks · 3h ago
  • Why Soaring Health Industry Stock DexCom is a Strong Buy Right Now
  • Zacks · 17h ago
  • Cramer's lightning round: 'You do want to buy defense stocks right here'
  • CNBC.com · 17h ago
  • Pump-manufacturing company seeing surge in demand amid pandemic
  • CNBC.com · 18h ago

Industry

Medical Equipment, Supplies & Distribution
+0.06%
Healthcare Equipment & Supplies
-0.41%

Hot Stocks

Symbol
Price
%Change

About DXCM

Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4 PLATINUM and DexCom G5 Mobile. The Company is commercializing its fifth generation CGM system. The Company's markets DexCom G4 PLATINUM under a Conformite Europeenne Marking (CE Mark), in the European Union, Australia, New Zealand and the countries in Asia and Latin America, and in the United States with approval from the United States Food and Drug Administration (FDA). The DexCom G4 PLATINUM with Share remote monitoring system uses a wireless connection between a patient's receiver and an application on the patient's iPhone, iPod touch, or iPad to transmit glucose information to applications on the mobile devices of designated recipients (followers).
More

Webull offers kinds of DexCom, Inc. stock information, including NASDAQ:DXCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXCM stock news, and many more online research tools to help you make informed decisions.